ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, D. R.
Right arrow Articles by Ollerenshaw, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, D. R.
Right arrow Articles by Ollerenshaw, J. D.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Peripheral vascular

Ann Thorac Surg 2001;71:S433-S436
© 2001 The Society of Thoracic Surgeons


Basic research

Transformation of nonvascular acellular tissue matrices into durable vascular conduits

David R. Clarke, MDa, Robert M. Lust, PhDb, You Su Sun, MDb, Kirby S. Black, PhDa, Jeremy D. Ollerenshaw, PhDa

a CryoLife Incorporated, Kennesaw, Georgia, USA
b Cardiovascular Research Laboratory, East Carolina University, Greenville, North Carolina, USA

Address reprint requests to Dr Ollerenshaw, CryoLife Inc, 1655 Roberts Blvd NW, Kennesaw, GA 30144
e-mail: ollerenshaw.jeremy{at}cryolife.com

Presented at the VIII International Symposium on Cardiac Bioprostheses, Cancun, Mexico, Nov 3–5, 2000.

Background. Prosthetic grafts commonly used for vascular reconstruction are limited to synthetics and cross-linked tissue grafts. Within these devices, graft infections are common, compliance mismatch is significant, and handling qualities are poor. Natural biological tissues that are unfixed have been shown to resist infections and be durable and compliant. A natural biological matrix that could be remodeled appropriately after implantation would be a desirable graft for vascular reconstruction.

Methods. SynerGraft tissue engineering strategies have been used to minimize antigenicity and produce stable unfixed vascular grafts from nonvascular bovine tissues. These grafts have replaced the abdominal aortas of 8 dogs that have been followed for up to 10 months.

Results. Early evaluation indicates rapid recellularization by recipient smooth muscle actin positive cells, which become arranged circumferentially, into the media. Arterioles were present in the adventitial areas and endothelial cells were seen to cover lumenal surfaces. After 10 months, grafts were patent and not aneurysmal.

Conclusions. These data indicate that SynerGraft processing of animal tissues is capable of producing stable vascular conduits that exhibit long-term functionality in other species.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Hoenig, G. R. Campbell, B. E. Rolfe, and J. H. Campbell
Tissue-Engineered Blood Vessels: Alternative to Autologous Grafts?
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1128 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Walles, H. Gorler, C. Puschmann, and H. Mertsching
Functional neointima characterization of vascular prostheses in human
Ann. Thorac. Surg., March 1, 2004; 77(3): 864 - 868.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.